DNA Ligase IV Protein
Overview
DNA Ligase IV (LIG4) is a critical DNA repair enzyme that catalyzes the final sealing step in non-homologous end joining (NHEJ), the primary pathway for repair of double-strand breaks (DSBs) in mammalian cells. The protein is encoded by the LIG4 gene located on chromosome 13q33-34 in humans. DNA Ligase IV functions as part of a multi-protein complex that includes XRCC4 (X-ray repair cross-complementing protein 4) and XLF/Cernunnos, collectively forming the core machinery of NHEJ. This enzyme is particularly abundant in neuronal tissues and is essential for genomic stability, with mutations in LIG4 associated with severe immunodeficiency and neurological dysfunction through impaired DNA repair capacity.
Function and Biology
DNA Ligase IV catalyzes the ligation of DNA strands by forming phosphodiester bonds between the 3' hydroxyl and 5' phosphate groups of adjacent DNA segments. The enzyme exhibits low basal activity in isolation but becomes highly activated through its interaction with XRCC4, which serves as a processivity factor and regulatory cofactor. This XRCC4-LIG4 heterodimer recognizes and binds to DSB intermediates processed by other NHEJ components, including the Ku70/Ku80 heterodimer and DNA-PKcs (DNA-dependent protein kinase catalytic subunit).
...DNA Ligase IV Protein
Overview
DNA Ligase IV (LIG4) is a critical DNA repair enzyme that catalyzes the final sealing step in non-homologous end joining (NHEJ), the primary pathway for repair of double-strand breaks (DSBs) in mammalian cells. The protein is encoded by the LIG4 gene located on chromosome 13q33-34 in humans. DNA Ligase IV functions as part of a multi-protein complex that includes XRCC4 (X-ray repair cross-complementing protein 4) and XLF/Cernunnos, collectively forming the core machinery of NHEJ. This enzyme is particularly abundant in neuronal tissues and is essential for genomic stability, with mutations in LIG4 associated with severe immunodeficiency and neurological dysfunction through impaired DNA repair capacity.
Function and Biology
DNA Ligase IV catalyzes the ligation of DNA strands by forming phosphodiester bonds between the 3' hydroxyl and 5' phosphate groups of adjacent DNA segments. The enzyme exhibits low basal activity in isolation but becomes highly activated through its interaction with XRCC4, which serves as a processivity factor and regulatory cofactor. This XRCC4-LIG4 heterodimer recognizes and binds to DSB intermediates processed by other NHEJ components, including the Ku70/Ku80 heterodimer and DNA-PKcs (DNA-dependent protein kinase catalytic subunit).
The catalytic mechanism of DNA Ligase IV involves adenylation of the enzyme via ATP hydrolysis, followed by transfer of the adenyl group to the 5' phosphate of the DNA break, and finally nucleophilic attack by the 3' hydroxyl group to complete strand ligation. The protein contains several functional domains: an N-terminal DNA-binding domain, a central catalytic domain, and a C-terminal XRCC4-binding domain. Post-translational modifications, including phosphorylation by DNA-PKcs and ubiquitination, regulate DNA Ligase IV activity and protein stability during DNA damage response.
Role in Neurodegeneration
DNA Ligase IV dysfunction contributes to neurodegeneration through mechanisms related to accumulation of unrepaired DSBs and genomic instability. The nervous system exhibits heightened vulnerability to DNA damage due to the high metabolic activity and oxidative stress characteristic of neurons. Neurons possess limited capacity to undergo apoptosis compared to other cell types, yet persistent DNA damage leads to activation of p53-mediated pathways and eventual neuronal death through apoptosis or other cell death mechanisms.
LIG4 deficiency impairs the resolution of DSBs generated during V(D)J recombination in developing lymphocytes and during normal neuronal processes such as topoisomerase II-mediated DNA strand breakage. Accumulation of unrepaired breaks triggers chronic activation of DNA damage checkpoints, leading to reduced neuronal proliferation during development and progressive neurodegeneration in the adult brain. The increased reactive oxygen species production and mitochondrial dysfunction secondary to persistent DNA damage further contributes to neuronal loss.
Molecular Mechanisms
At the molecular level, DNA Ligase IV dysfunction promotes neurodegeneration through several interconnected pathways. Impaired NHEJ capacity results in accumulation of unrepaired DSBs, triggering sustained p53 activation and induction of pro-apoptotic genes including BAX and PUMA. The checkpoint kinase ATM (ataxia telangiectasia mutated) remains persistently activated in the absence of efficient DSB repair, leading to extended cell cycle arrest and eventual terminal apoptosis.
Additionally, defective DNA Ligase IV compromises the fidelity of NHEJ, increasing the likelihood of aberrant ligation events that generate deletions, inversions, or translocations. These genomic rearrangements may further destabilize neuronal homeostasis and compromise the expression of critical neuroprotective genes. The protein's direct interaction with XRCC4 is essential for these functions; mutations disrupting this interaction result in loss of enzymatic activity and accumulation of DNA damage.
Clinical and Research Significance
Mutations in LIG4 cause LIG4 syndrome, a rare autosomal recessive disorder characterized by severe immunodeficiency, microcephaly, growth retardation, and progressive neurological dysfunction including intellectual disability and cerebellar ataxia. Patients with LIG4 syndrome exhibit marked genomic instability and increased cancer predisposition. Understanding DNA Ligase IV dysfunction has implications for broader neurodegenerative conditions associated with impaired DNA repair, including Alzheimer's disease and frontotemporal dementia, where DSB accumulation has been documented.
- Non-homologous end joining (NHEJ)
- XRCC4 protein
- XLF/Cernunnos
- DNA-PKcs
- Ku70/Ku80 heterodimer
- Double-strand break repair
- LIG4 syndrome
- V(D)J recombination
- Genomic instability
- Neuronal apoptosis